Literature DB >> 22695917

Canonical and non-canonical Notch signaling in CD4⁺ T cells.

Lisa M Minter1, Barbara A Osborne.   

Abstract

For T cells to become fully activated, they must integrate a myriad of signals, both extrinsic and intrinsic. External stimuli accrued through various cell surface receptors are transduced and amplified through a coordinated circuitry of signaling cascades that ultimately result in the transcription of new genes. Along the way, extracellular and intracellular signaling components function to impart a fully activated state. Evidence is accumulating to show that the Notch family of cell surface receptors, long known to function as transcriptional regulators through their interactions with the canonical nuclear binding protein CSL/RBP-J, may also be playing an as-yet-unappreciated role in T cell activation by virtue of its signaling via non-canonical as well as nonnuclear mechanisms. In this review we will discuss these and other better-known means by which Notch signaling influences T cell responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695917     DOI: 10.1007/82_2012_233

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  21 in total

1.  Notch1 primes CD4 T cells for T helper type I differentiation through its early effects on miR-29.

Authors:  Karthik Chandiran; Rebecca Lawlor; Antonio Pannuti; Gabriela Gonzalez Perez; Janani Srinivasan; Todd E Golde; Lucio Miele; Barbara A Osborne; Lisa M Minter
Journal:  Mol Immunol       Date:  2018-05-26       Impact factor: 4.407

2.  Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co-stimulation.

Authors:  Karen Laky; Sharron Evans; Ainhoa Perez-Diez; B J Fowlkes
Journal:  Immunity       Date:  2015-01-01       Impact factor: 31.745

3.  Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.

Authors:  Rosa A Sierra; Jimena Trillo-Tinoco; Eslam Mohamed; Lolie Yu; Bhagelu R Achyut; Ali Arbab; Jennifer W Bradford; Barbara A Osborne; Lucio Miele; Paulo C Rodriguez
Journal:  Cancer Res       Date:  2017-09-13       Impact factor: 12.701

4.  Notching tumor: Signaling through Notch receptors improves antitumor T cell immunity.

Authors:  Roman Uzhachenko; Anil Shanker
Journal:  Oncoimmunology       Date:  2016-01-11       Impact factor: 8.110

Review 5.  The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.

Authors:  Nazanin Arjomand Fard; Gholamreza Azizi; Abbas Mirshafiey
Journal:  Innov Clin Neurosci       Date:  2016-08-01

6.  T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells.

Authors:  Ashley R Sandy; Jooho Chung; Tomomi Toubai; Gloria T Shan; Ivy T Tran; Ann Friedman; Timothy S Blackwell; Pavan Reddy; Philip D King; Ivan Maillard
Journal:  J Immunol       Date:  2013-05-01       Impact factor: 5.422

7.  Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.

Authors:  Wipawee Wongchana; Rebecca G Lawlor; Barbara A Osborne; Tanapat Palaga
Journal:  J Immunol       Date:  2015-10-26       Impact factor: 5.422

8.  Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer.

Authors:  Rosa A Sierra; Paul Thevenot; Patrick L Raber; Yan Cui; Chris Parsons; Augusto C Ochoa; Jimena Trillo-Tinoco; Luis Del Valle; Paulo C Rodriguez
Journal:  Cancer Immunol Res       Date:  2014-05-15       Impact factor: 11.151

Review 9.  Targeting Notch in oncology: the path forward.

Authors:  Samarpan Majumder; Judy S Crabtree; Todd E Golde; Lisa M Minter; Barbara A Osborne; Lucio Miele
Journal:  Nat Rev Drug Discov       Date:  2020-12-08       Impact factor: 84.694

10.  Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.

Authors:  Justine E Roderick; Gabriela Gonzalez-Perez; Christina Arieta Kuksin; Anushka Dongre; Emily R Roberts; Janani Srinivasan; Chester Andrzejewski; Abdul H Fauq; Todd E Golde; Lucio Miele; Lisa M Minter
Journal:  J Exp Med       Date:  2013-06-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.